Pathos AI

Company ● Covered in 1 story + Follow ✴ AI Graph

This profile is built automatically from TLDRocket coverage.

Signals

1 story (new)

Media momentum

As of 23 Oct 2026 · Visible stories in the last 30 days, compared with the 30 days before.

1 source

Source diversity

As of 23 Oct 2026 · Distinct publications behind this entity's visible coverage.

—

Release activity

As of 23 Oct 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.

—

Funding signals

As of 23 Oct 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.

Oct 2026

Coverage span

As of 23 Oct 2026 · First to most recent month of TLDRocket coverage of this entity.

Funding history

$237M Other announced 23 Oct 2026 coverage →

Bristol Myers Squibb NEA

Latest developments

AI drug development startup Pathos AI closes $237M investment SiliconANGLE · 2 hours ago · 16

Timeline

Month Quarter Year

October 2026

Bristol Myers Squibb invests in Pathos AI Funding

AstraZeneca invests in Pathos AI Funding

NEA invests in Pathos AI Funding

General Atlantic invests in Pathos AI Funding

23 Oct AI drug development startup Pathos AI closes $237M investment

Relationships

Products & technology

Integrated with Pathos AI Foundry AI · 1 source

Investment & ownership

Bristol Myers Squibb invests in this company · 1 source
AstraZeneca invests in this company · 1 source
NEA invests in this company · 1 source
General Atlantic invests in this company · 1 source

Every AI story that matters,
in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.